Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin
Factores pronósticos y de riesgo de recidiva en una serie de 385 pacientes con carcinoma vesical superficial tratados con tiotepa, adriamicina o cisplatino